These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20618326)

  • 1. Dabigatran offers the simplest solution for thromboprophylaxis after orthopaedic surgery in patients allergic to low-molecular-weight heparins.
    Garcia-Ortega P; Asencio J
    Br J Haematol; 2010 Oct; 151(1):84-5. PubMed ID: 20618326
    [No Abstract]   [Full Text] [Related]  

  • 2. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A combination of arteriovenous impulse system and low-molecular-weight heparins calcium for prophylaxis of deep venous thrombosis following total knee arthroplasty].
    Cao J; Wang J; Zhang H; Wang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 May; 24(5):538-40. PubMed ID: 20540254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged thromboprophylaxis with low molecular weight heparin after major abdominal surgery.
    Rasmussen MS
    Curr Opin Pulm Med; 2007 Sep; 13(5):389-92. PubMed ID: 17940482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trials of venous thromboembolism prevention.
    Norrie J
    Lancet; 2007 Sep; 370(9591):915-7. PubMed ID: 17869620
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dabigatran in the treatment of a morbidly obese patient with recurring venous thrombosis].
    Callejas Rubio JL; Lara Jiménez MA; Fernández Pugnaire MA; Ortego Centeno N
    Farm Hosp; 2010; 34(2):101. PubMed ID: 20304372
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing postsurgical venous thromboembolism: pharmacological approaches.
    Tufano A; Coppola A; Cerbone AM; Ruosi C; Franchini M
    Semin Thromb Hemost; 2011 Apr; 37(3):252-66. PubMed ID: 21455859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anaesthesia and thromboembolic disease].
    Llau JV; Sapena ML; López Forte C; Ferrandis R
    Med Clin (Barc); 2008 Nov; 131 Suppl 2():42-7. PubMed ID: 19087850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness analysis of methods for thromboprophylaxis after orthopedic surgery].
    Omel'ianovskiĭ VV; Zagorodniĭ NV; Margieva AV; Tsfasman FM
    Khirurgiia (Mosk); 2010; (5):72-81. PubMed ID: 20568660
    [No Abstract]   [Full Text] [Related]  

  • 11. A new approach with anticoagulant development: tailoring anticoagulant therapy with dabigatran etexilate according to patient risk.
    Rosencher N; Albaladejo P
    Expert Opin Pharmacother; 2012 Feb; 13(2):217-26. PubMed ID: 22192174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.
    Eikelboom JW; Mazzarol A; Quinlan DJ; Beaver R; Williamson J; Yi Q; Hankey GJ;
    Haematologica; 2004 May; 89(5):586-93. PubMed ID: 15136222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Budget impact analysis of Pradaxa thromboprophylaxis after total hip or total knee replacement].
    Bouée S; Zufferey P; Fagnani F
    Therapie; 2009; 64(4):249-57. PubMed ID: 19804705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
    Friedman RJ
    Orthopedics; 2009 Dec; 32(12 Suppl):79-84. PubMed ID: 20201481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolism prophylaxis with dabigatran leads to lower perioperative blood loss than with dalteparin in primary knee arthroplasty.
    Matziolis D; Matziolis G; Perka C
    Arch Orthop Trauma Surg; 2011 Dec; 131(12):1739-43. PubMed ID: 21660479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
    Eriksson BI; Dahl OE; Rosencher N; Kurth AA; van Dijk CN; Frostick SP; Kälebo P; Christiansen AV; Hantel S; Hettiarachchi R; Schnee J; Büller HR;
    J Thromb Haemost; 2007 Nov; 5(11):2178-85. PubMed ID: 17764540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thrombosis prophylaxis with low-molecular-weight heparin in hip and knee arthroplasty.
    Colwell CW
    Instr Course Lect; 2002; 51():487-9. PubMed ID: 12064138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
    Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Venous thromboprophylaxis postcaesarean: survey of practices in Lorraine].
    Vial F; Hein F; Boileau S; Vedel M; Bouaziz H
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):395-6. PubMed ID: 19303734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.